Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Ucello Therapeutics | 2023 | Series A | $21.2M | Chengdu |
| Galxe | 2023 | Series A | Undisclosed | San Mateo |
| Fivetran | 2023 | Debt Financing | $125.0M | Oakland |
| Basedash | 2023 | Seed | $3.1M | Montréal |
| Excell Biology | 2023 | Series B | $14.4M | Shanghai |
| Joes Future Food | 2023 | Series A | Undisclosed | Nanjing |
| Ampersand | 2023 | Seed | $4.7M | San Francisco |
| Family Zone | 2023 | Post Ipo Equity | $20.0M | Perth |
| Frontis | 2023 | Angel | Undisclosed | Haidian |
| Procural | 2023 | Seed | $1.2M | Sitrah |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 201 | Ucello Therapeutics | Series A | $21.2M | Chengdu, China |
| 202 | Galxe | Series A | Undisclosed | San Mateo, United States |
| 203 | Fivetran | Debt Financing | $125.0M | Oakland, United States |
| 204 | Basedash | Seed | $3.1M | Montréal, Canada |
| 205 | Excell Biology | Series B | $14.4M | Shanghai, China |
| 206 | Joes Future Food | Series A | Undisclosed | Nanjing, China |
| 207 | Ampersand | Seed | $4.7M | San Francisco, United States |
| 208 | Family Zone | Post Ipo Equity | $20.0M | Perth, Australia |
| 209 | Frontis | Angel | Undisclosed | Haidian, China |
| 210 | Procural | Seed | $1.2M | Sitrah, Bahrain |
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Galxe is the leading Web3 credential data network in the world.
Fivetran is a technology company that automates replicating data into a cloud data platforms.
The fastest way to make an admin panel.
Excell Biology is a supplier of raw materials to the biopharmaceutical and precision medicine industries.
Joes Future Food engages the development, production, testing, and sales of raw and auxiliary materials for food and biological products.
Ampersand is a development platform for user-facing SaaS integrations.
Family Zone brings together the best cyber experts, organisations and technologies into one easy-to-use system.
Frontis is a provider of artificial intelligence technology solutions.
Seeking Intelligent Control provides cloud-based multi-dimensional data analysis and rapid quality control equipment services.
Grakn is a knowledge graph engine designed to structure intricate data networks and enable querying through knowledge engineering.
Aluna provides an at-home spirometer to maintain healthy lung function.
Evertas is a crypto insurance company that develops regulated insurance and risk mitigation solutions for crypto assets.
nference is a software company that creates transformative technologies and products in healthcare.
Wildxyz is an art creator platform.
CommonGround-AI provides a new 3D video platform.
X-EPIC is a Nanjing city-based startup aimed at building up China’s own EDA (Electronic Design Automation) industrial software technology.
Thin Red Line is a technology company building the next-generation personal computing device platform after the smartphone.
Sieve supplies video data to frontier AI labs.
Owl Labs builds cutting-edge technology that creates deeply immersive collaborative experiences.
Braavos is a smart contract based wallet for managing your funds & NFTs and connecting to dApps.
Choco CRM is a professional CRM & POS solutions for business.
Qidi Technology is a high-tech enterprise that is early in researching, developing, and marketing 3D printers.
vesoft is the creator of the lightning-fast open-source distributed graph database #Nebula Graph#
Matrix has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Matrix's top investment sectors include Software, Information Technology, Artificial Intelligence (AI), Biotechnology, Blockchain. The firm invests across 52 different industry categories.
Among tracked funding rounds, Fivetran received $125.0M in a Debt Financing round. Matrix's total known invested capital is $2.2B.
Matrix's average investment size is $25.6M across its portfolio of 467 companies.
Recent Matrix portfolio additions include Ucello Therapeutics, Galxe, Fivetran, Basedash, Excell Biology. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors